Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Analytical estimation methods for determination of sorafenib

Breadcrumb

  • Home
  • Analytical estimation methods for determination of sorafenib

Thangabalan Boovizhikannan *, Jagadish Kuruba, Mahasweta Goswami and Bhavya Maddineni

Department of Pharmaceutical Analysis, Sri Venkateswara College of Pharmacy, RVS Nagar, Tirupati Rd, Chittoor, Andhra Pradesh 517127, India.

Review Article
 
World Journal of Biology Pharmacy and Health Sciences, 2022, 12(02), 016–026.
Article DOI: 10.30574/wjbphs.2022.12.2.0184
DOI url: https://doi.org/10.30574/wjbphs.2022.12.2.0184

Received on 27 September 2022; revised on 04 Noveber 2022; accepted on 07 November 2022

Sorafenib is an anticancer drug is used to treat late stage kidney and liver cancer. Sorafenib is used to treat advanced renal cell carcinoma (RCC; a type of cancer that begins in the kidneys). Sorafenib is also used to treat hepatocellular carcinoma (a type of liver cancer) that cannot be treated with surgery and a certain type of thyroid cancer that has spread to other parts of the body and cannot be treated with radioactive iodine. Sorafenib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells. There are many reported analytical methods for estimation of Sorafenib. The present work list outs the various analytical methods for the estimation of the drug. 

Sorafenib; Antineoplastic agent; Estimation methods;c

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2022-0184.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Thangabalan Boovizhikannan, Jagadish Kuruba, Mahasweta Goswami and Bhavya Maddineni. Analytical estimation methods for determination of sorafenib. World Journal of Biology Pharmacy and Health Sciences, 2022, 12(02), 016–026. Article DOI: https://doi.org/10.30574/wjbphs.2022.12.2.0184

 

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution